跳至主要内容
临床试验/NCT05151796
NCT05151796Unknown不适用

Effect of Continuation of Aspirin Before Isolated Heart Valve Surgery on Postoperative Bleeding and Transfusion: a Single-center Retrospective Study

University of Liege1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2012年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
The number of units of packed red blood cells transfused anytime during the hospital stay

研究概览

简要总结

Whether or not continuing aspirin up to de day before surgery increases the risk of bleeding and/or prevents thrombo-embolic complications remains debated. The investigators retrospectively investigated the whether continuing aspirine within 5 days of isolated heart valve surgery increased the risk of bleeding.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Isolated heart valve surgery

排除标准

  • Antiplatelet agent other than aspirin or anticoagulant not discontinued preoperatively
  • Emergent or salvage surgery
  • Surgery for endocarditis
  • Use of NSAIDs within 48 hours before surgery

研究组 & 干预措施

Aspirin continued within 5 days before surgery

干预措施: Aspirin (Drug)

结局指标

主要结局

The number of units of packed red blood cells transfused anytime during the hospital stay

时间窗: 30 days

次要结局

  • Transfusion of any type of blood product(30 days)
  • Chest tube drainage(24 hours)
  • Any thrombo-embolic complication(30 days)
  • Surgical revision for bleeding(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jean François Brichant

Professor of Anesthesia

University of Liege

研究点 (1)

Loading locations...

相似试验

Continuation of Aspirin Before Isolated Heart Valve... | 临床试验